Advancing Patient Care: Innovative Use of Near-Infrared Spectroscopy for Monitoring Urine Volume in Neurogenic Bladder
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose: Current guidelines recommend clean intermittent catheterization (CIC) at regular time intervals for patients with spinal cord injuries; however, many patients experience difficulties. Performing time-based CIC outside the home is a significant burden for patients. In this study, we aimed to overcome the limitations of the current guidelines by developing a digital device to monitor bladder urine volume in real-time. Methods: The optode sensor is a near-infrared spectroscopy (NIRS)-based wearable device intended to be attached to the skin of the lower abdomen where the bladder is located. The sensor’s primary function is to detect changes in urine volume within the bladder. An in vitro study was conducted using a bladder phantom that mimicked the optical properties of the lower abdomen. To validate the data in the human body at the proof-of-concept level, one volunteer attached the device to the lower abdomen to measure the light intensity between the first voiding and immediately before the second voiding. Results: The degree of attenuation at the maximum test volume was equivalent across experiments, and the optode sensor with multiplex measurements demonstrated robust performance for patient diversity. Moreover, the symmetric feature of the matrix was deemed a potential parameter for identifying the accuracy of sensor localization in a deep-learning model. The validated feasibility of the sensor showed almost the same results as an ultrasound scanner, which is routinely used in the clinical field. Conclusions: The optode sensor of the NIRS-based wearable device can measure the urine volume in the bladder in real-time.
Abstract
Purpose: Current guidelines recommend clean intermittent catheterization (CIC) at regular time intervals for patients with spinal cord injuries; however, many patients experience difficulties. Performing time-based CIC outside the home is a significant burden for patients. In this study, we aimed to overcome the limitations of the current guidelines by developing a digital device to monitor bladder urine volume in real-time. Methods: The optode sensor is a near-infrared spectroscopy (NIRS)-based wearable device intended to be attached to the skin of the lower abdomen where the bladder is located. The sensor’s primary function is to detect changes in urine volume within the bladder. An in vitro study was conducted using a bladder phantom that mimicked the optical properties of the lower abdomen. To validate the data in the human body at the proof-of-concept level, one volunteer attached the device to the lower abdomen to measure the light intensity between the first voiding and immediately before the second voiding. Results: The degree of attenuation at the maximum test volume was equivalent across experiments, and the optode sensor with multiplex measurements demonstrated robust performance for patient diversity. Moreover, the symmetric feature of the matrix was deemed a potential parameter for identifying the accuracy of sensor localization in a deep-learning model. The validated feasibility of the sensor showed almost the same results as an ultrasound scanner, which is routinely used in the clinical field. Conclusions: The optode sensor of the NIRS-based wearable device can measure the urine volume in the bladder in real-time.
참고문헌 (18)
- Panicker JN, "Neurogenic bladder: epidemiology, diagnosis, and management", Semin Neurol, 40, pp.569~579 (2020)
- Manack A, "Epidemiology and healthcare utilization of neurogenic bladder patients in a US claims database", Neurourol Urodyn, 30, pp.395~401 (2011)
- Panicker JN, "Lower urinary tract dysfunction in the neurological patient : clinical assessment and management", Lancet Neurol, 14, pp.720~732 (2015)
- Wyndaele JJ, "The management of neurogenic lower urinary tract dysfunction after spinal cord injury", Nat Rev Urol, 13, pp.705~714 (2016)
- Taweel WA, "Neurogenic bladder in spinal cord injury patients", Res Rep Urol, 10, pp.85~99 (2015)
- Verpoorten C, "The neurogenic bladder : medical treatment", Pediatr Nephrol, 23, pp.717~725 (2008)
- Stöhrer M, "EAU guidelines on neurogenic lower urinary tract dysfunction", Eur Urol, 56, pp.81~88 (2009)
- Ginsberg DA, "The AUA", SUFU guideline on adult neurogenic lower urinary tract dysfunction : diagnosis and evaluation, 2021, pp.206, 1097~1105
- Ginsberg DA, "The AUA", SUFU guideline on adult neurogenic lower urinary tract dysfunction : Treatment and follow-up, 2021, pp.206, 1106~1113
- Bakker A, "Applied aspects of ultrasonography in humans", pp.65~88 (2012), Intech Open
- Ferrari M, "A brief review on the history of human functional near-infrared spectroscopy(fNIRS)development and fields of application", Neuroimage, 63, pp.921~935 (2012)
- Miyai I, "Longitudinal optical imaging study for frequency-domain near-infrared spectroscopy", J Biomed Opt, 9, pp.845~850 (2004)
- Molavi B, "Non-invasive optical monitoring of bladder filling to capacity using a wireless near infrared spectroscopy device", IEEE Trans Biomed Circuits Syst, 8, pp.325~333 (2014)
- Koven A, "NIRS: past, present, and future in functional urology", Curr Bladder Dysfunct Rep, 17, pp.241~249 (2022)
- Bashkatov AN, "Optical properties of human skin, subcutaneous and mucous tissues in the wavelength range from 400 to 2000 nm", J Phys D Appl Phys, 38, pp.2543~2555 (2005)
- Lam JH, "Narrowband diffuse reflectance spectroscopy in the 900-1000 nm wavelength region to quantify water and lipid content of turbid media", Biomed Opt Express, 12, pp.3091~3102 (2021)
- Radin JM, "Harnessing wearable device data to improve state level real-time surveillance of influenza-like illness in the USA : a population-based study", Lancet Digital Health, 2, pp.e85~e93 (2020)
- Ates HC, "End-to-end design of wearable sensors", Nat Rev Mater, 7, pp.887~907 (2022)